| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |